Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by FredZarfloonon Nov 30, 2021 2:56pm
88 Views
Post# 34181644

RE:RE:RE:RE:OHIP

RE:RE:RE:RE:OHIPSo if Aristotle is a private, client paid test - why do you need a (OHIP paid?) physicians referral to get it? Or is that just the first step to an expensive Circle of Care program for those who can afford it - and not for those who can't.

I can see this being a simple matter in the US, but Canada is still governed by the Canada Health Act. Sometimes hard to reconcile these public/private arrangements.

By the way, SZLS website states AVRD is not availvable in Canada. What happened to Toronto? 


gojotv! wrote:

I doubt that OHIP, or any Canadian government health program covers Aristotle testing for now, mostly because SZLS doesn't have Health Canada's or the FDA's stamp yet, but that's what it took to get it to market before going broke doing studies.
That said, there's a lot of good info for patients and physicians available on these two pages from the Care Oncology website...
Among other things, they claim (second link) to be actively recruiting telehealth physicians... A pretty good deal for doctors who wants to log some useful hours working from home...

Things are heating up...

https://careoncology.com/care-oncology-providers/

https://careoncology.com/a-note-to-our-fellow-health-care-providers/

 




<< Previous
Bullboard Posts
Next >>